Crossmark

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection

Crossref DOI link: https://doi.org/10.1186/s12985-018-1015-6

Published Online: 2018-07-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kikuti, Mariana

Tauro, Laura B.

Moreira, Patrícia S. S.

Campos, Gúbio S.

Paploski, Igor A. D.

Weaver, Scott C.

Reis, Mitermayer G.

Kitron, Uriel

Ribeiro, Guilherme S. https://orcid.org/0000-0002-6798-2059
Funding

Funding for this research was provided by:

Brazilian National Council for Scientific and Technological Development (550160/2010-8, 400830/2013-2)

Brazilian National Council for Scientific and Technological Development (440891/2016-7)

Bahia Foundation for Research Support (PNX0010/2011, PPP0055/2011, PET0026/2013, APP0044/2016)

Bahia Foundation for Research Support (JCB0020/2013, PET0022/2016)
License Information

Text and Data Mining valid from 2018-07-13
More Information

Article History

Received: 28 February 2018

Accepted: 29 June 2018

First Online: 13 July 2018

Ethics approval and consent to participate

: This project was approved by the Research Ethics Committee at the Gonçalo Moniz Institute, Oswaldo Cruz Foundation. All adult subjects provided written informed consent. Participants < 18 years old who could read provided written assent following written consent from their parent or guardian. All study data were anonymized before analysis.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.